Puranik Ameya D, Nair Gopinathan, Aggarwal Rajiv, Bandyopadhyay Abhijit, Shinto Ajit, Zade Anand
Department of Nuclear Medicine, Narayana Hrudayalaya Institute of Medical Sciences, Bangalore, Karnataka, India.
Indian J Nucl Med. 2013 Apr;28(2):79-84. doi: 10.4103/0972-3919.118240.
The study aimed at developing a scoring system for scintigraphic grading of gastro-esophageal reflux (GER), on gastro-esophageal reflux scintigraphy (GERS) and comparison of clinical and scintigraphic scores, pre- and post-treatment.
A total of 39 cases with clinically symptomatic GER underwent 99mTc sulfur colloid GERS; scores were assigned based on the clinical and scintigraphic parameters. Post domperidone GERS was performed after completion of treatment. Follow up GERS was performed and clinical and scintigraphic parameters were compared with baseline parameters.
Paired t-test on pre and post domperidone treatment clinical scores showed that the decline in post-treatment scores was highly significant, with P value < 0.001. The scintigraphic scoring system had a sensitivity of 93.9% in assessing treatment response to domperidone, specificity of 83.3% i.e., 83.3% of children with no decline in scintigraphic scores show no clinical response to Domperidone. The scintigraphic scoring system had a positive predictive value of 96.9% and a negative predictive value of 71.4%.
GERS with its quantitative parameters is a good investigation for assessing the severity of reflux and also for following children post-treatment.
本研究旨在开发一种用于胃食管反流(GER)闪烁显像分级的评分系统,应用于胃食管反流闪烁显像(GERS),并比较治疗前后的临床评分和闪烁显像评分。
共有39例有临床症状的GER患者接受了99mTc硫胶体GERS检查;根据临床和闪烁显像参数进行评分。治疗完成后进行多潘立酮治疗后的GERS检查。进行随访GERS检查,并将临床和闪烁显像参数与基线参数进行比较。
多潘立酮治疗前后临床评分的配对t检验显示,治疗后评分下降非常显著,P值<0.001。闪烁显像评分系统在评估对多潘立酮的治疗反应时,敏感性为93.9%,特异性为83.3%,即闪烁显像评分无下降的儿童中83.3%对多潘立酮无临床反应。闪烁显像评分系统的阳性预测值为96.9%,阴性预测值为71.4%。
具有定量参数的GERS是评估反流严重程度以及治疗后随访儿童的良好检查方法。